Advances in pharmacological strategies for the prevention of cataract development.
about
Multifunctional antioxidants for the treatment of age-related diseasesComparison of the impact of epigallocatechin gallate and ellagic acid in an experimental cataract model induced by sodium selenite.A silent mutation in human alpha-A crystallin gene in patients with age-related nuclear or cortical cataract.Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental modelsRole of Cytochrome Modulators in Altering the Occurrence of Cataract in RatsTherapeutic targets of renin-angiotensin system in ocular disorders.Contribution of cholesterol and oxysterols in the physiopathology of cataract: implication for the development of pharmacological treatmentsNatural flavonoids as potential multifunctional agents in prevention of diabetic cataract.Mechanism of the anticataract effect of liposomal MgT in galactose-fed rats.Effect of rifampicin and erythromycin on the initiation of galactose induced cataract in rats.Evaluation of anticataract potential of Triphala in selenite-induced cataract: In vitro and in vivo studies.Scopoletin inhibits rat aldose reductase activity and cataractogenesis in galactose-fed rats.Expression of SIRT1 and P53 in Rat Lens Epithelial cells in Experimentally Induced DM.Histological and histometrical study of the protective role of α-tocopherol against sodium arsenite toxicity in rat ovaries.Functional food supplements to ameliorate the secondary complications in high fructose fed diabetic rats.Inhibitory effect of r-hirudin variant III on streptozotocin-induced diabetic cataracts in rats.
P2860
Q33524505-738755DC-16CB-4E78-A7AB-025318331CD3Q33607702-05D9D4C8-A5CA-4096-A380-62D54C1D1397Q33808712-7875D30D-B8BC-45F2-80E7-720928780A3CQ34528903-CDF4F9FF-687C-4769-A01A-EF05E8E66BB6Q36068093-61B36D58-CEC7-42B4-9431-1EE00A58FE1CQ39214578-5B25A551-B81C-4302-8265-8460E7DA28EEQ41879279-91A44A31-2113-4B2B-90BA-C92C16321AB0Q41890624-C0E314AE-90B2-441D-AD7C-626A46F0FFCEQ41985198-DE549CCF-0969-497B-A564-8F2B9FAF6B13Q42079483-D6C857FC-9EF7-4769-8543-60E0E5DE59D9Q42730935-8AC3748D-7BF2-4E96-B046-DC4E9A550407Q42963737-B52806E2-28A3-46B0-970C-DC940ADDCAE3Q47336389-C7F157D6-8893-4ACA-8915-280DE0AEB94BQ48604198-D2A8D4A7-FBD1-4EB9-9409-C596097F55F5Q51061448-D730D84B-49D5-4A85-9F49-4F7CCA393408Q54372385-92766436-A065-4162-9770-3294448A89E7
P2860
Advances in pharmacological strategies for the prevention of cataract development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in pharmacological strategies for the prevention of cataract development.
@en
Advances in pharmacological strategies for the prevention of cataract development.
@nl
type
label
Advances in pharmacological strategies for the prevention of cataract development.
@en
Advances in pharmacological strategies for the prevention of cataract development.
@nl
prefLabel
Advances in pharmacological strategies for the prevention of cataract development.
@en
Advances in pharmacological strategies for the prevention of cataract development.
@nl
P2093
P2860
P921
P356
P1476
Advances in pharmacological strategies for the prevention of cataract development.
@en
P2093
Rohit Saxena
S S Agrawal
V Kalai Selvan
P2860
P304
P356
10.4103/0301-4738.49390
P407
P5008
P577
2009-05-01T00:00:00Z